MetLife Investment Management’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.33M | Sell |
36,686
-204
| -0.6% | -$26.8K | 0.02% | 680 |
|
|
2025
Q4 | $4.39M | Sell |
36,890
-2,087
| -5% | -$238K | 0.02% | 680 |
|
|
2025
Q3 | $3.9M | Sell |
38,977
-1,320
| -3% | -$157K | 0.02% | 750 |
|
|
2025
Q2 | $5.2M | Buy |
40,297
+137
| +0.3% | +$16.7K | 0.03% | 563 |
|
|
2025
Q1 | $5.14M | Sell |
40,160
-1,141
| -3% | -$164K | 0.03% | 602 |
|
|
2024
Q4 | $6.31M | Buy |
41,301
+3,081
| +8% | +$522K | 0.03% | 438 |
|
|
2024
Q3 | $6.84M | Sell |
38,220
-726
| -2% | -$126K | 0.04% | 380 |
|
|
2024
Q2 | $6.35M | Buy |
38,946
+1,621
| +4% | +$263K | 0.04% | 380 |
|
|
2024
Q1 | $6.52M | Sell |
37,325
-974
| -3% | -$160K | 0.04% | 372 |
|
|
2023
Q4 | $6.45M | Sell |
38,299
-316
| -0.8% | -$46.1K | 0.05% | 341 |
|
|
2023
Q3 | $5.54M | Sell |
38,615
-938
| -2% | -$153K | 0.04% | 366 |
|
|
2023
Q2 | $7.28M | Sell |
39,553
-141
| -0.4% | -$23.1K | 0.05% | 288 |
|
|
2023
Q1 | $6.31M | Sell |
39,694
-587
| -1% | -$90.1K | 0.05% | 340 |
|
|
2022
Q4 | $5.47M | Sell |
40,281
-692
| -2% | -$96.9K | 0.04% | 383 |
|
|
2022
Q3 | $4.74M | Buy |
40,973
+22,489
| +122% | +$3.06M | 0.04% | 432 |
|
|
2022
Q2 | $2.24M | Hold |
18,484
| – | – | 0.02% | 855 |
|
|
2022
Q1 | $2.63M | Buy |
18,484
+6,085
| +49% | +$863K | 0.02% | 881 |
|
|
2021
Q4 | $2.19M | Hold |
12,399
| – | – | 0.02% | 838 |
|
|
2021
Q3 | $1.92M | Hold |
12,399
| – | – | 0.02% | 874 |
|
|
2021
Q2 | $1.67M | Hold |
12,399
| – | – | 0.01% | 942 |
|
|
2021
Q1 | $1.64M | Sell |
12,399
-1,793
| -13% | -$236K | 0.02% | 940 |
|
|
2020
Q4 | $1.68M | Hold |
14,192
| – | – | 0.02% | 911 |
|
|
2020
Q3 | $1.49M | Sell |
14,192
-842
| -6% | -$89K | 0.02% | 848 |
|
|
2020
Q2 | $1.61M | Buy |
15,034
+1,161
| +8% | +$108K | 0.02% | 817 |
|
|
2020
Q1 | $1.11M | Hold |
13,873
| – | – | 0.02% | 860 |
|
|
2019
Q4 | $1.23M | Sell |
13,873
-1,072
| -7% | -$92.5K | 0.01% | 996 |
|
|
2019
Q3 | $1.22M | Hold |
14,945
| – | – | 0.01% | 973 |
|
|
2019
Q2 | $1.41M | Buy |
14,945
+1,180
| +9% | +$101K | 0.02% | 961 |
|
|
2019
Q1 | $1.17M | Hold |
13,765
| – | – | 0.01% | 1017 |
|
|
2018
Q4 | $867K | Hold |
13,765
| – | – | 0.01% | 1080 |
|
|
2018
Q3 | $942K | Sell |
13,765
-1,584
| -10% | -$111K | 0.01% | 1157 |
|
|
2018
Q2 | $956K | Hold |
15,349
| – | – | 0.01% | 1036 |
|
|
2018
Q1 | $800K | Hold |
15,349
| – | – | 0.01% | 1109 |
|
|
2017
Q4 | $767K | Buy |
+15,349
| New | +$748K | 0.01% | 1154 |
|
Other funds holding NOVT
VPM
VCM
CCA
WA
GCM
MetLife Investment Management's NOVT Position: Q1 2026 in Review
MetLife Investment Management reduced its Novanta (NOVT) stake by 0.55% in Q1 2026, selling an estimated $26.8K and leaving 36,686 shares worth $4.33M. The position accounts for 0.02% of the portfolio, ranked #680.
MetLife Investment Management first reported a position in NOVT in Q4 2017 and has held it in 34 quarters since. The position peaked at $7.28M in Q2 2023. 330 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.
- MetLife Investment Management held 36,686 shares of Novanta worth $4.33M as of Q1 2026.
- MetLife Investment Management sold 204 Novanta shares in Q1 2026, an estimated $26.8K.
- Novanta made up 0.02% of MetLife Investment Management's portfolio in Q1 2026, its #680 holding.
- MetLife Investment Management first reported a position in Novanta in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Novanta position peaked at $7.28M in Q2 2023.
- 330 funds tracked by Wall St. Rank held Novanta as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.